Still waiting after 110 years: the optimal use of ovarian ablation as adjuvant therapy for breast cancer

J Clin Oncol. 2006 Nov 1;24(31):4949-51. doi: 10.1200/JCO.2006.07.9160.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Adult
  • Amenorrhea / chemically induced
  • Amenorrhea / etiology*
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / radiotherapy*
  • Breast Neoplasms / surgery
  • Chemotherapy, Adjuvant
  • Estrogen Receptor Modulators / therapeutic use
  • Female
  • Humans
  • Menopause, Premature
  • Middle Aged
  • Multicenter Studies as Topic
  • Ovary / radiation effects*
  • Premenopause*
  • Radiotherapy, Adjuvant
  • Randomized Controlled Trials as Topic
  • Recovery of Function
  • Tamoxifen / therapeutic use

Substances

  • Antineoplastic Agents, Hormonal
  • Estrogen Receptor Modulators
  • Tamoxifen